| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH6 ABCF3 IPO8 DNAH10 MYO7B MYO18A PSMC4 DDX51 ATP8B1 MORC2 ATAD2 KIF20A ATP6V1H DDX46 MDN1 ASCC3 TOR3A KIF17 | 2.75e-07 | 614 | 139 | 18 | GO:0140657 |
| GeneOntologyMolecularFunction | calcium:monoatomic cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration | 3.30e-07 | 3 | 139 | 3 | GO:1905060 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCF3 DNAH10 MYO18A PSMC4 DDX51 ATP8B1 MORC2 ATAD2 KIF20A ATP6V1H DDX46 MDN1 ASCC3 TOR3A KIF17 | 4.59e-07 | 441 | 139 | 15 | GO:0016887 |
| GeneOntologyMolecularFunction | calcium:sodium antiporter activity | 3.82e-05 | 10 | 139 | 3 | GO:0005432 | |
| GeneOntologyMolecularFunction | monoatomic ion antiporter activity involved in regulation of postsynaptic membrane potential | 4.81e-05 | 2 | 139 | 2 | GO:0099580 | |
| GeneOntologyMolecularFunction | calcium:monoatomic cation antiporter activity | 8.97e-05 | 13 | 139 | 3 | GO:0015368 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.78e-04 | 118 | 139 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCF3 DNAH10 MYO18A PSMC4 DDX51 ATP8B1 MORC2 ATAD2 KIF20A ATP6V1H DDX46 MDN1 ASCC3 TOR3A KIF17 | 3.34e-04 | 775 | 139 | 15 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCF3 DNAH10 MYO18A PSMC4 DDX51 ATP8B1 MORC2 ATAD2 KIF20A ATP6V1H DDX46 MDN1 ASCC3 TOR3A KIF17 | 7.60e-04 | 839 | 139 | 15 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCF3 DNAH10 MYO18A PSMC4 DDX51 ATP8B1 MORC2 ATAD2 KIF20A ATP6V1H DDX46 MDN1 ASCC3 TOR3A KIF17 | 7.69e-04 | 840 | 139 | 15 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCF3 DNAH10 MYO18A PSMC4 DDX51 ATP8B1 MORC2 ATAD2 KIF20A ATP6V1H DDX46 MDN1 ASCC3 TOR3A KIF17 | 7.69e-04 | 840 | 139 | 15 | GO:0016818 |
| GeneOntologyCellularComponent | sarcomere | 5.14e-06 | 249 | 135 | 10 | GO:0030017 | |
| GeneOntologyCellularComponent | Z disc | 6.28e-06 | 151 | 135 | 8 | GO:0030018 | |
| GeneOntologyCellularComponent | supramolecular fiber | MYH6 DNAH10 MAP2 KRT82 MYO18A FHOD3 SYNC KIF20A EFHC2 NARF STK11 SLC8A2 SLC8A1 SLC8A3 DST GRK3 SYNE2 AKAP13 MYOM2 KIF17 RPL6 TBCA | 6.58e-06 | 1179 | 135 | 22 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MYH6 DNAH10 MAP2 KRT82 MYO18A FHOD3 SYNC KIF20A EFHC2 NARF STK11 SLC8A2 SLC8A1 SLC8A3 DST GRK3 SYNE2 AKAP13 MYOM2 KIF17 RPL6 TBCA | 7.32e-06 | 1187 | 135 | 22 | GO:0099081 |
| GeneOntologyCellularComponent | myofibril | 1.15e-05 | 273 | 135 | 10 | GO:0030016 | |
| GeneOntologyCellularComponent | I band | 1.26e-05 | 166 | 135 | 8 | GO:0031674 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.94e-05 | 290 | 135 | 10 | GO:0043292 | |
| GeneOntologyCellularComponent | postsynaptic density | MAP2 SYNDIG1 GRM1 SLC8A2 SLC8A1 SLC8A3 DST GRK3 DGCR8 MAP3K7 RPL6 KPNA2 | 3.71e-05 | 451 | 135 | 12 | GO:0014069 |
| GeneOntologyCellularComponent | asymmetric synapse | MAP2 SYNDIG1 GRM1 SLC8A2 SLC8A1 SLC8A3 DST GRK3 DGCR8 MAP3K7 RPL6 KPNA2 | 6.35e-05 | 477 | 135 | 12 | GO:0032279 |
| GeneOntologyCellularComponent | nuclear body | CASP8AP2 ICE2 MSL1 ATP8B1 SHQ1 ZNF106 CACTIN DDX46 SF3B1 SATB1 YLPM1 TRIM8 EHMT1 DGCR8 ASCC3 GNL3 S100PBP | 7.35e-05 | 903 | 135 | 17 | GO:0016604 |
| GeneOntologyCellularComponent | postsynapse | MAP2 UBE3B PSMA7 CAPN2 SYNDIG1 GRM1 SLC8A2 SLC8A1 SLC8A3 DST GRK3 AP2B1 SRGAP3 DGCR8 MAP3K7 KIF17 RPL6 KPNA2 | 9.88e-05 | 1018 | 135 | 18 | GO:0098794 |
| GeneOntologyCellularComponent | postsynaptic specialization | MAP2 SYNDIG1 GRM1 SLC8A2 SLC8A1 SLC8A3 DST GRK3 DGCR8 MAP3K7 RPL6 KPNA2 | 1.05e-04 | 503 | 135 | 12 | GO:0099572 |
| GeneOntologyCellularComponent | nuclear periphery | 1.25e-04 | 171 | 135 | 7 | GO:0034399 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | MAP2 SYNDIG1 GRM1 SLC8A2 SLC8A1 SLC8A3 DST GRK3 DGCR8 MAP3K7 RPL6 KPNA2 | 1.51e-04 | 523 | 135 | 12 | GO:0098984 |
| GeneOntologyCellularComponent | myosin filament | 5.46e-04 | 25 | 135 | 3 | GO:0032982 | |
| GeneOntologyCellularComponent | MLL1 complex | 1.14e-03 | 32 | 135 | 3 | GO:0071339 | |
| GeneOntologyCellularComponent | MLL1/2 complex | 1.25e-03 | 33 | 135 | 3 | GO:0044665 | |
| GeneOntologyCellularComponent | dendritic shaft | 1.35e-03 | 74 | 135 | 4 | GO:0043198 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | BICD2 RBBP5 ICE2 POU2AF1 NCL RELB JMJD1C THOC5 MEN1 FANCB CACTIN DDX46 SF3B1 SYNE2 NUP133 SMARCE1 DGCR8 ASCC3 TAF6 | 1.38e-03 | 1377 | 135 | 19 | GO:0140513 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | DNAH10 MAP2 KRT82 SYNC KIF20A EFHC2 NARF SLC8A2 SLC8A1 SLC8A3 DST AKAP13 KIF17 TBCA | 2.05e-03 | 899 | 135 | 14 | GO:0099513 |
| GeneOntologyCellularComponent | nuclear matrix | 2.17e-03 | 140 | 135 | 5 | GO:0016363 | |
| Domain | Na_Ca_Ex | 3.69e-07 | 3 | 135 | 3 | IPR004836 | |
| Domain | Na_Ca_Ex_C-exten | 3.69e-07 | 3 | 135 | 3 | IPR032452 | |
| Domain | Na_Ca_ex_C | 3.69e-07 | 3 | 135 | 3 | PF16494 | |
| Domain | P-loop_NTPase | MYH6 ABCF3 DNAH10 MYO7B MYO18A PSMC4 DDX51 ATAD2 NLRP2 KIF20A DDX46 TRANK1 MDN1 YLPM1 NMRK1 N4BP2L2 ASCC3 TOR3A KIF17 HYDIN GNL3 | 7.54e-07 | 848 | 135 | 21 | IPR027417 |
| Domain | ARM-like | IPO8 RTTN FHOD3 ATAD2 ATP6V1H SF3B1 AP1B1 AP2B1 XPO6 TAF6 KPNA2 | 4.32e-06 | 270 | 135 | 11 | IPR011989 |
| Domain | - | 4.96e-06 | 222 | 135 | 10 | 1.25.10.10 | |
| Domain | - | ABCF3 DNAH10 MYO7B MYO18A PSMC4 DDX51 ATAD2 NLRP2 DDX46 TRANK1 MDN1 YLPM1 NMRK1 N4BP2L2 ASCC3 TOR3A HYDIN GNL3 | 7.22e-06 | 746 | 135 | 18 | 3.40.50.300 |
| Domain | Calx_beta | 2.01e-05 | 8 | 135 | 3 | SM00237 | |
| Domain | Calx_beta | 3.01e-05 | 9 | 135 | 3 | IPR003644 | |
| Domain | NaCa_Exmemb | 3.01e-05 | 9 | 135 | 3 | IPR004837 | |
| Domain | Na_Ca_ex | 3.01e-05 | 9 | 135 | 3 | PF01699 | |
| Domain | Calx-beta | 3.01e-05 | 9 | 135 | 3 | PF03160 | |
| Domain | Clathrin_b-adaptin_app_Ig-like | 5.19e-05 | 2 | 135 | 2 | IPR013037 | |
| Domain | - | 5.19e-05 | 2 | 135 | 2 | 2.60.40.1150 | |
| Domain | AP_complex_bsu_1_2_4 | 1.55e-04 | 3 | 135 | 2 | IPR016342 | |
| Domain | PEHE | 1.55e-04 | 3 | 135 | 2 | PF15275 | |
| Domain | PEHE | 1.55e-04 | 3 | 135 | 2 | SM01300 | |
| Domain | PEHE_dom | 1.55e-04 | 3 | 135 | 2 | IPR029332 | |
| Domain | B2-adapt-app_C | 1.55e-04 | 3 | 135 | 2 | PF09066 | |
| Domain | ARM-type_fold | 1.80e-04 | 339 | 135 | 10 | IPR016024 | |
| Domain | B2-adapt-app_C | 3.08e-04 | 4 | 135 | 2 | SM01020 | |
| Domain | B-adaptin_app_sub_C | 3.08e-04 | 4 | 135 | 2 | IPR015151 | |
| Domain | AP_beta | 5.11e-04 | 5 | 135 | 2 | IPR026739 | |
| Domain | Spectrin | 5.88e-04 | 23 | 135 | 3 | PF00435 | |
| Domain | AAA | 6.29e-04 | 144 | 135 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 6.29e-04 | 144 | 135 | 6 | IPR003593 | |
| Domain | Beta2_adaptin/TBP_C_dom | 7.63e-04 | 6 | 135 | 2 | IPR012295 | |
| Domain | - | 7.63e-04 | 6 | 135 | 2 | 3.30.310.10 | |
| Domain | Spectrin_repeat | 1.18e-03 | 29 | 135 | 3 | IPR002017 | |
| Domain | Coatomer/calthrin_app_sub_C | 1.41e-03 | 8 | 135 | 2 | IPR009028 | |
| Domain | EF_HAND_2 | 1.47e-03 | 231 | 135 | 7 | PS50222 | |
| Domain | EF_hand_dom | 1.50e-03 | 232 | 135 | 7 | IPR002048 | |
| Domain | SPEC | 1.57e-03 | 32 | 135 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.57e-03 | 32 | 135 | 3 | IPR018159 | |
| Domain | IQ | 1.74e-03 | 71 | 135 | 4 | PF00612 | |
| Domain | Alpha_adaptinC2 | 1.81e-03 | 9 | 135 | 2 | PF02883 | |
| Domain | Clathrin_a/b/g-adaptin_app_Ig | 1.81e-03 | 9 | 135 | 2 | IPR008152 | |
| Domain | Alpha_adaptinC2 | 1.81e-03 | 9 | 135 | 2 | SM00809 | |
| Domain | SCGB | 1.81e-03 | 9 | 135 | 2 | PS51311 | |
| Domain | Uteroglobin | 2.25e-03 | 10 | 135 | 2 | PF01099 | |
| Domain | Myosin_head_motor_dom | 2.59e-03 | 38 | 135 | 3 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 2.59e-03 | 38 | 135 | 3 | PS51456 | |
| Domain | Myosin_head | 2.59e-03 | 38 | 135 | 3 | PF00063 | |
| Domain | MYSc | 2.59e-03 | 38 | 135 | 3 | SM00242 | |
| Domain | Secretoglobin | 2.73e-03 | 11 | 135 | 2 | IPR016126 | |
| Domain | IQ | 2.83e-03 | 81 | 135 | 4 | SM00015 | |
| Domain | - | 2.92e-03 | 261 | 135 | 7 | 1.10.238.10 | |
| Domain | ARM | 3.00e-03 | 40 | 135 | 3 | SM00185 | |
| Domain | Coatomer/clathrin_app_Ig-like | 3.26e-03 | 12 | 135 | 2 | IPR013041 | |
| Domain | IQ_motif_EF-hand-BS | 4.13e-03 | 90 | 135 | 4 | IPR000048 | |
| Domain | IMPORTIN_B_NT | 4.46e-03 | 14 | 135 | 2 | PS50166 | |
| Domain | ATPase_dyneun-rel_AAA | 4.46e-03 | 14 | 135 | 2 | IPR011704 | |
| Domain | AAA_5 | 4.46e-03 | 14 | 135 | 2 | PF07728 | |
| Domain | IQ | 4.64e-03 | 93 | 135 | 4 | PS50096 | |
| Domain | Armadillo | 4.75e-03 | 47 | 135 | 3 | IPR000225 | |
| Domain | EF-hand-dom_pair | 4.90e-03 | 287 | 135 | 7 | IPR011992 | |
| Domain | EF-hand_1 | 4.97e-03 | 152 | 135 | 5 | PF00036 | |
| Domain | Clathrin/coatomer_adapt-like_N | 5.12e-03 | 15 | 135 | 2 | IPR002553 | |
| Domain | Spectrin_alpha_SH3 | 5.12e-03 | 15 | 135 | 2 | IPR013315 | |
| Domain | Adaptin_N | 5.12e-03 | 15 | 135 | 2 | PF01602 | |
| Domain | IBN_N | 5.12e-03 | 15 | 135 | 2 | PF03810 | |
| Domain | IBN_N | 5.82e-03 | 16 | 135 | 2 | SM00913 | |
| Domain | Importin-beta_N | 6.57e-03 | 17 | 135 | 2 | IPR001494 | |
| Domain | TPR_REGION | 6.99e-03 | 165 | 135 | 5 | PS50293 | |
| Domain | TPR | 6.99e-03 | 165 | 135 | 5 | PS50005 | |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 5.01e-05 | 11 | 97 | 3 | M27336 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 6.64e-05 | 12 | 97 | 3 | M27326 | |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 8.59e-05 | 13 | 97 | 3 | MM15078 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 1.09e-04 | 14 | 97 | 3 | MM15052 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | CASP8AP2 RBBP5 SPTA1 DDX51 RNF40 MSL1 NCL JMJD1C THOC5 MEN1 KIF20A ZNF106 CACTIN DDX46 SF3B1 DST MDN1 ZBED4 YLPM1 NUP133 EHMT1 SMARCE1 TAF6 RPL6 GNL3 KPNA2 | 1.02e-11 | 1294 | 139 | 26 | 30804502 |
| Pubmed | CASP8AP2 EIF4H RBBP5 PSMA7 CAPN2 RNF40 NCL MORC2 THOC5 CACTIN DDX46 SF3B1 MDN1 YLPM1 NUP133 EHMT1 SMARCE1 TAF6 MAGEC2 GNL3 | 4.39e-09 | 1014 | 139 | 20 | 32416067 | |
| Pubmed | CASP8AP2 IPO8 EIF4H MAP2 PSMA7 NUCB2 MYO18A PSMC4 NCL DNAJB7 THOC5 STT3A CACTIN SF3B1 MDN1 SYNE2 NUP133 EHMT1 AKAP13 ASCC3 SIPA1L2 RPL6 EDRF1 GNL3 | 5.45e-09 | 1487 | 139 | 24 | 33957083 | |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | IPO8 PSMA7 STK38 PSMC4 DDX51 RNF40 NCL SF3B1 AP1B1 RPL6 GNL3 KPNA2 | 6.12e-09 | 316 | 139 | 12 | 31665637 |
| Pubmed | DNAH10 RBBP5 B3GALNT2 PSMA7 MYO18A PSMC4 MSL1 RELB MORC2 JMJD1C STT3A FHAD1 FAT1 DST SATB1 SYNE2 YLPM1 EHMT1 SMARCE1 CEP152 TAF6 GNL3 | 5.86e-08 | 1429 | 139 | 22 | 35140242 | |
| Pubmed | DDX51 NCL ATAD2 DDX46 SF3B1 DST MDN1 AP1B1 AP2B1 SYNE2 YLPM1 NUP133 ASCC3 RPL6 GNL3 | 6.19e-08 | 653 | 139 | 15 | 22586326 | |
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 21382638 | ||
| Pubmed | The downregulation of NCXs is positively correlated with the prognosis of stage II-IV colon cancer. | 6.25e-08 | 3 | 139 | 3 | 34127021 | |
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 29594857 | ||
| Pubmed | Aberrant Amygdala-Dependent Cued Fear Memory in Na+/Ca2+ Exchanger 1 Heterozygous Mice. | 6.25e-08 | 3 | 139 | 3 | 30324228 | |
| Pubmed | Sodium-calcium exchange in intracellular calcium handling of human airway smooth muscle. | 6.25e-08 | 3 | 139 | 3 | 21858195 | |
| Pubmed | Immunosuppressive drugs, immunophilins, and functional expression of NCX isoforms. | 6.25e-08 | 3 | 139 | 3 | 23224887 | |
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 23224890 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 23224882 | ||
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 17317768 | ||
| Pubmed | MYH6 SPTA1 PSMA7 NUCB2 MYO18A IFIT5 MSL1 NCL RNF17 MEN1 STK11 SF3B1 DST MDN1 ZBED4 AP2B1 SYNE2 YLPM1 OGDHL MYOM2 SIPA1L2 RPL6 | 6.86e-08 | 1442 | 139 | 22 | 35575683 | |
| Pubmed | 6.96e-08 | 187 | 139 | 9 | 26460568 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | RBBP5 MSL1 MORC2 ATAD2 JMJD1C MEN1 KIF20A FSIP2 CACTIN SATB1 EHMT1 SMARCE1 GNL3 KPNA2 | 1.70e-07 | 608 | 139 | 14 | 36089195 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | BICD2 IPO8 EIF4H STK38 MSL1 KIF20A EDEM3 FANCB ZNF106 DDX46 SF3B1 AP2B1 YLPM1 NUP133 EHMT1 SMARCE1 CEP152 GNL3 KPNA2 | 1.89e-07 | 1155 | 139 | 19 | 20360068 |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | MYH6 MAP2 SPTA1 CAPN2 MYO18A PSMC4 NCL DST SATB1 AP1B1 AP2B1 SRGAP3 PKD2 RPL6 | 2.19e-07 | 621 | 139 | 14 | 22794259 |
| Pubmed | 2.49e-07 | 4 | 139 | 3 | 29274751 | ||
| Pubmed | Calcineurin inhibits Na+/Ca2+ exchange in phenylephrine-treated hypertrophic cardiomyocytes. | 2.49e-07 | 4 | 139 | 3 | 15557343 | |
| Pubmed | 2.49e-07 | 4 | 139 | 3 | 12581871 | ||
| Pubmed | ABCF3 RBBP5 RNF40 SYNC CCDC6 STT3A DDX46 SF3B1 AP1B1 AP2B1 YLPM1 OGDHL TAF6 GNL3 | 4.00e-07 | 653 | 139 | 14 | 33742100 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | BICD2 MYO18A DDX51 NCL CCDC6 MORC2 ATAD2 ZNF106 CACTIN DDX46 SF3B1 MDN1 XPO6 YLPM1 TAF6 | 5.40e-07 | 774 | 139 | 15 | 15302935 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | EIF4H PSMA7 MYO18A STK38 PSMC4 NCL DDX46 SF3B1 DST MDN1 AP1B1 AP2B1 ASCC3 MAP3K7 RPL6 GNL3 TBCA KPNA2 | 8.25e-07 | 1149 | 139 | 18 | 35446349 |
| Pubmed | 9.85e-07 | 332 | 139 | 10 | 37433992 | ||
| Pubmed | NUCB2 PSMC4 NCL RELB STT3A EDEM3 ZNF106 FAT1 ATP6V1H SF3B1 DST AP2B1 SYNE2 EHMT1 AKAP13 TOR3A RPL6 GNL3 KPNA2 | 1.08e-06 | 1297 | 139 | 19 | 33545068 | |
| Pubmed | Sodium/calcium exchanger expression in the mouse and rat olfactory systems. | 1.24e-06 | 6 | 139 | 3 | 17311327 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | MAP2 MYO18A STK38 NCL THOC5 STT3A DDX46 SF3B1 DST ZBED4 AP2B1 YLPM1 EHMT1 SMARCE1 SIPA1L2 RPL6 KPNA2 | 1.64e-06 | 1082 | 139 | 17 | 38697112 |
| Pubmed | 1.73e-06 | 90 | 139 | 6 | 31280863 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ABCF3 EIF4H PSMA7 CAPN2 PSMC4 DDX51 NCL ATAD2 KIF20A SF3B1 DST MDN1 AP2B1 NUP133 AKAP13 PRMT3 ASCC3 RPL6 GNL3 | 2.01e-06 | 1353 | 139 | 19 | 29467282 |
| Pubmed | 2.12e-06 | 52 | 139 | 5 | 20462248 | ||
| Pubmed | Inhibitory interaction of the plasma membrane Na+/Ca2+ exchangers with the 14-3-3 proteins. | 2.16e-06 | 7 | 139 | 3 | 16679322 | |
| Pubmed | 2.16e-06 | 7 | 139 | 3 | 12781968 | ||
| Pubmed | CASP8AP2 IPO8 MYO18A STK38 RNF40 NCL MORC2 RNF17 STT3A SF3B1 SYNE2 EHMT1 SMARCE1 KPNA2 | 2.17e-06 | 754 | 139 | 14 | 35906200 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | ABCF3 IPO8 EIF4H PSMA7 CAPN2 MYO18A PSMC4 NCL STT3A ATP6V1H DDX46 SF3B1 AP1B1 SYNE2 YLPM1 SMARCE1 RPL6 TBCA KPNA2 | 2.33e-06 | 1367 | 139 | 19 | 32687490 |
| Pubmed | IPO8 HDX STK38 PSMC4 NCL CCDC6 SF3B1 PRMT3 MAP3K7 RPL6 GNL3 KPNA2 | 2.39e-06 | 551 | 139 | 12 | 34728620 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | IPO8 DNAH10 RBBP5 PSMA7 PSMC4 NCL GRM1 ATAD2 STT3A ATP6V1H SF3B1 MDN1 NUP133 EHMT1 SMARCE1 PRMT3 RPL6 GNL3 KPNA2 | 4.25e-06 | 1425 | 139 | 19 | 30948266 |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | NCL STT3A DDX46 SF3B1 AP1B1 AP2B1 SMARCE1 ASCC3 RPL6 GNL3 KPNA2 | 4.45e-06 | 486 | 139 | 11 | 30940648 |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | CASP8AP2 EIF4H PSMA7 PSMC4 MSL1 NCL RELB CCDC6 KIF20A STK11 ZBED4 YLPM1 EHMT1 TBCA KPNA2 | 4.62e-06 | 922 | 139 | 15 | 27609421 |
| Pubmed | Intersectin (ITSN) family of scaffolds function as molecular hubs in protein interaction networks. | 5.87e-06 | 111 | 139 | 6 | 22558309 | |
| Pubmed | BTB-ZF factors recruit the E3 ligase cullin 3 to regulate lymphoid effector programs. | 7.07e-06 | 31 | 139 | 4 | 23086144 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PDE4A LONRF1 UBE3B RTTN RNF40 RELB FAT1 CYREN DST MDN1 ZBED4 XPO6 EHMT1 OGDHL AKAP13 SIPA1L2 | 9.45e-06 | 1105 | 139 | 16 | 35748872 |
| Pubmed | NUCB2 MYO18A THOC5 STK11 ZNF106 SCGB2A1 ATP6V1H DST MDN1 AP2B1 SMARCE1 RPL6 | 9.88e-06 | 634 | 139 | 12 | 34591612 | |
| Pubmed | IPO8 PSMC4 DDX46 SF3B1 MDN1 AP1B1 AP2B1 NUP133 PRMT3 ASCC3 GNL3 KPNA2 | 1.05e-05 | 638 | 139 | 12 | 33239621 | |
| Pubmed | IPO8 RTTN NCL STT3A DDX46 SF3B1 AP1B1 YLPM1 NUP133 RPL6 GNL3 KPNA2 | 1.10e-05 | 641 | 139 | 12 | 36057605 | |
| Pubmed | EIF4H IFIT5 MSL1 MORC2 ATAD2 MEN1 KIF20A ATP6V1H DST CEP152 MAP3K7 EDRF1 | 1.17e-05 | 645 | 139 | 12 | 25281560 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | IPO8 MYO18A DDX51 NCL DDX46 MDN1 NUP133 OGDHL DGCR8 ASCC3 RPL6 GNL3 KPNA2 | 1.20e-05 | 759 | 139 | 13 | 35915203 |
| Pubmed | IPO8 PSMA7 HDX PSMC4 STT3A ATP6V1H SF3B1 NUP133 TOR3A MAP3K7 RPL6 GNL3 | 1.41e-05 | 657 | 139 | 12 | 36180527 | |
| Pubmed | MYO18A PSMC4 DNAJB7 THOC5 MEN1 DDX46 SF3B1 DST AP2B1 YLPM1 NUP133 KPNA2 | 1.47e-05 | 660 | 139 | 12 | 32780723 | |
| Pubmed | PSMC4 MSL1 JMJD1C FANCB ZNF106 DDX46 SF3B1 MDN1 SMARCE1 DGCR8 | 1.52e-05 | 453 | 139 | 10 | 29656893 | |
| Pubmed | BICD2 LONRF1 IFIT5 RNF40 SYNC CCDC6 MOAP1 SF3B1 DST SATB1 AP2B1 YLPM1 TRIM8 N4BP2L2 SMARCE1 DGCR8 TAF6 | 1.57e-05 | 1285 | 139 | 17 | 35914814 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 23137542 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 33931447 | ||
| Pubmed | The organization of the human gene NCX1 encoding the sodium-calcium exchanger. | 1.59e-05 | 2 | 139 | 2 | 8921376 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 18416968 | ||
| Pubmed | Characterization of the aberrant splicing of MAP3K7 induced by cancer-associated SF3B1 mutation. | 1.59e-05 | 2 | 139 | 2 | 33751071 | |
| Pubmed | Ca2+ regulation in the Na+/Ca2+ exchanger features a dual electrostatic switch mechanism. | 1.59e-05 | 2 | 139 | 2 | 19667209 | |
| Pubmed | Roles of Na(+)/Ca(2+) exchanger isoforms NCX1 and NCX2 in motility in mouse ileum. | 1.59e-05 | 2 | 139 | 2 | 27411318 | |
| Pubmed | Na+/Ca2+ exchanger contributes to stool transport in mice with experimental diarrhea. | 1.59e-05 | 2 | 139 | 2 | 27928109 | |
| Pubmed | Genetic knockout and pharmacologic inhibition of NCX2 cause natriuresis and hypercalciuria. | 1.59e-05 | 2 | 139 | 2 | 25498502 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 15151203 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 24925404 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 29941946 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 17085580 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 26787195 | ||
| Pubmed | The E3 ligase tripartite motif 8 targets TAK1 to promote insulin resistance and steatohepatitis. | 1.59e-05 | 2 | 139 | 2 | 27981609 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 26971467 | ||
| Pubmed | Molecular and functional characterization of the human platelet Na(+) /Ca(2+) exchangers. | 1.59e-05 | 2 | 139 | 2 | 21790537 | |
| Pubmed | SF3B1 mutant-induced missplicing of MAP3K7 causes anemia in myelodysplastic syndromes. | 1.59e-05 | 2 | 139 | 2 | 34930825 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 27995356 | ||
| Pubmed | NCX as a key player in the neuroprotection exerted by ischemic preconditioning and postconditioning. | 1.59e-05 | 2 | 139 | 2 | 23224883 | |
| Pubmed | The role of the mitochondrial NCX in the mechanism of neurodegeneration in Parkinson's disease. | 1.59e-05 | 2 | 139 | 2 | 23224884 | |
| Pubmed | Human macrophages and monocytes express functional Na(+)/Ca (2+) exchangers 1 and 3. | 1.59e-05 | 2 | 139 | 2 | 23224891 | |
| Pubmed | RBBP5 CAPN2 PSMC4 DDX51 THOC5 ATP6V1H AP1B1 AP2B1 NUP133 EHMT1 PRMT3 | 1.67e-05 | 560 | 139 | 11 | 35241646 | |
| Pubmed | ABCF3 EIF4H MYO18A PSMC4 DDX51 RNF40 NCL STT3A MDN1 AP2B1 NUP133 AKAP13 ASCC3 RPL6 GNL3 KPNA2 | 1.86e-05 | 1168 | 139 | 16 | 19946888 | |
| Pubmed | 2.23e-05 | 209 | 139 | 7 | 36779422 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | EIF4H MYO18A IFIT5 DDX51 NCL CACTIN DDX46 SF3B1 YLPM1 ASCC3 GNL3 TBCA KPNA2 | 2.28e-05 | 807 | 139 | 13 | 22681889 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | ABCF3 RBBP5 PSMC4 RNF17 DDX46 SF3B1 MDN1 AP1B1 XPO6 YLPM1 KPNA2 | 2.38e-05 | 582 | 139 | 11 | 20467437 |
| Pubmed | 2.53e-05 | 383 | 139 | 9 | 29331416 | ||
| Pubmed | CASP8AP2 MYO18A NCL MUC12 ZNF106 SF3B1 DST AP2B1 AKAP13 MAP3K7 | 2.77e-05 | 486 | 139 | 10 | 20936779 | |
| Pubmed | 3.18e-05 | 494 | 139 | 10 | 26831064 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 3.34e-05 | 497 | 139 | 10 | 36774506 | |
| Pubmed | 3.37e-05 | 16 | 139 | 3 | 8798769 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | DDX51 NCL DDX46 SF3B1 MDN1 YLPM1 SMARCE1 ASCC3 RPL6 GNL3 KPNA2 | 3.38e-05 | 605 | 139 | 11 | 28977666 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | BICD2 ABCF3 EIF4H ICE2 MYO18A MORC2 THOC5 KIF20A YLPM1 EHMT1 AKAP13 ASCC3 | 3.63e-05 | 724 | 139 | 12 | 36232890 |
| Pubmed | RBBP5 DDX51 NCL ATAD2 STT3A MEN1 DDX46 MDN1 NUP133 EHMT1 SMARCE1 RPL6 KPNA2 | 3.76e-05 | 847 | 139 | 13 | 35850772 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | ABCF3 RBBP5 RELB MORC2 JMJD1C MEN1 SF3B1 MDN1 SATB1 NUP133 SMARCE1 TOR3A KPNA2 | 4.24e-05 | 857 | 139 | 13 | 25609649 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | PSMC4 DDX51 NCL ATAD2 JMJD1C KIF20A ZNF106 SF3B1 MDN1 YLPM1 DGCR8 RPL6 GNL3 KPNA2 | 4.50e-05 | 989 | 139 | 14 | 36424410 |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 29551690 | ||
| Pubmed | Regulation of the Wnt signalling component PAR1A by the Peutz-Jeghers syndrome kinase LKB1. | 4.75e-05 | 3 | 139 | 2 | 12879020 | |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 24603286 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 22084099 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 31110137 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 27956576 | ||
| Pubmed | Genome-wide analysis of menin binding provides insights into MEN1 tumorigenesis. | 4.75e-05 | 3 | 139 | 2 | 16604156 | |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 12022875 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 29505555 | ||
| Pubmed | Role of Nesprin-2 and RanBP2 in BICD2-associated brain developmental disorders. | 4.75e-05 | 3 | 139 | 2 | 36930595 | |
| Interaction | NANOG interactions | IPO8 RBBP5 HDX PSMC4 RELB JMJD1C THOC5 MEN1 PPP2R3A MDN1 EHMT1 TOR3A SIPA1L2 GNL3 KPNA2 | 1.01e-06 | 481 | 137 | 15 | int:NANOG |
| Interaction | NUP43 interactions | BICD2 CASP8AP2 RBBP5 MSL1 MORC2 ATAD2 JMJD1C FSIP2 CACTIN DST SYNE2 NUP133 EHMT1 SMARCE1 TAF6 GNL3 | 5.54e-06 | 625 | 137 | 16 | int:NUP43 |
| Interaction | GSK3B interactions | BICD2 EIF4H CAPN2 NCL RELB CCDC6 NLRP2 STK11 SF3B1 DST AP1B1 AP2B1 XPO6 CEP152 PRMT3 ASCC3 SIPA1L2 MAP3K7 RPL6 | 6.69e-06 | 868 | 137 | 19 | int:GSK3B |
| Interaction | IFI16 interactions | IPO8 PSMA7 STK38 PSMC4 DDX51 RNF40 NCL ATAD2 MEN1 KIF20A SF3B1 AP1B1 NUP133 ASCC3 RPL6 GNL3 KPNA2 | 7.21e-06 | 714 | 137 | 17 | int:IFI16 |
| Interaction | GAN interactions | 9.24e-06 | 253 | 137 | 10 | int:GAN | |
| Interaction | ITSN1 interactions | 1.13e-05 | 259 | 137 | 10 | int:ITSN1 | |
| Interaction | GSK3A interactions | FLT3 EIF4H MAP2 CCDC6 DST MDN1 NUP133 CEP152 PRMT3 ASCC3 SIPA1L2 RPL6 KPNA2 | 1.73e-05 | 464 | 137 | 13 | int:GSK3A |
| Interaction | POLR1G interactions | PSMC4 DDX51 NCL MORC2 MEN1 KIF20A ZNF106 CACTIN MDN1 EHMT1 RPL6 GNL3 KPNA2 | 2.99e-05 | 489 | 137 | 13 | int:POLR1G |
| Interaction | CHD3 interactions | RBBP5 DDX51 NCL TTR MEN1 DDX46 SF3B1 MDN1 SATB1 YLPM1 SMARCE1 ASCC3 TAF6 RPL6 GNL3 KPNA2 | 5.75e-05 | 757 | 137 | 16 | int:CHD3 |
| Interaction | HDAC1 interactions | BICD2 CASP8AP2 RBBP5 RNF40 CCDC6 JMJD1C THOC5 MEN1 KIF20A DST SATB1 SYNE2 EHMT1 SMARCE1 PRRG4 PRMT3 ASCC3 TAF6 KPNA2 S100PBP | 6.03e-05 | 1108 | 137 | 20 | int:HDAC1 |
| Interaction | BAP1 interactions | EIF4H PSMA7 MYO18A STK38 MEIOB PSMC4 NCL CCDC6 STK11 FAT1 DDX46 SF3B1 DST MDN1 AP1B1 AP2B1 ASCC3 MAP3K7 RPL6 GNL3 TBCA KPNA2 | 7.60e-05 | 1314 | 137 | 22 | int:BAP1 |
| Cytoband | 6q15 | 1.12e-04 | 31 | 138 | 3 | 6q15 | |
| GeneFamily | EF-hand domain containing | 1.03e-04 | 219 | 89 | 7 | 863 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 2.02e-03 | 51 | 89 | 3 | 870 | |
| GeneFamily | Secretoglobins | 2.10e-03 | 14 | 89 | 2 | 734 | |
| GeneFamily | AAA ATPases | 2.26e-03 | 53 | 89 | 3 | 413 | |
| GeneFamily | DNA helicases | 3.11e-03 | 17 | 89 | 2 | 1167 | |
| GeneFamily | Armadillo repeat containing|Importins | 3.48e-03 | 18 | 89 | 2 | 596 | |
| Coexpression | GSE22611_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_2H_DN | 5.93e-06 | 183 | 138 | 8 | M8178 | |
| Coexpression | GSE17721_LPS_VS_GARDIQUIMOD_0.5H_BMDC_DN | 1.14e-05 | 200 | 138 | 8 | M4039 | |
| Coexpression | GSE3982_DC_VS_NEUTROPHIL_UP | 1.14e-05 | 200 | 138 | 8 | M5461 | |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | BICD2 CASP8AP2 PDE4A PSMA7 CAPN2 NUCB2 MYO18A MSL1 MORC2 JMJD1C ATP6V1H SYNE2 PKD2 AKAP13 KPNA2 | 1.89e-05 | 790 | 138 | 15 | M12490 |
| Coexpression | GSE3920_IFNB_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN | 4.38e-05 | 177 | 138 | 7 | M6703 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ATP8B1 CCDC6 FAT1 PPP2R3A ATP6V1H DST MDN1 XPO6 SYNE2 PKD2 NUP133 N4BP2L2 AKAP13 PRMT3 ASCC3 | 4.73e-05 | 856 | 138 | 15 | M4500 |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | CASP8AP2 ICE2 B3GALNT2 PSMA7 MSL1 NCL ATAD2 KIF20A FRMD4A SF3B1 FEZ2 NUP133 SMARCE1 CEP152 PRMT3 ASCC3 RPL6 EDRF1 KPNA2 S100PBP | 4.89e-05 | 1407 | 138 | 20 | M14427 |
| Coexpression | GSE37534_PIOGLITAZONE_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP | 5.60e-05 | 184 | 138 | 7 | M8990 | |
| Coexpression | GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 8.60e-05 | 197 | 138 | 7 | M5351 | |
| Coexpression | GSE22886_NEUTROPHIL_VS_MONOCYTE_UP | 8.60e-05 | 197 | 138 | 7 | M4466 | |
| Coexpression | GSE12366_GC_VS_NAIVE_BCELL_UP | 8.88e-05 | 198 | 138 | 7 | M3168 | |
| Coexpression | GSE12366_GC_VS_MEMORY_BCELL_UP | 8.88e-05 | 198 | 138 | 7 | M3171 | |
| Coexpression | GSE29949_CD8_POS_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_DN | 9.16e-05 | 199 | 138 | 7 | M8415 | |
| Coexpression | GSE17580_UNINFECTED_VS_S_MANSONI_INF_TREG_UP | 9.16e-05 | 199 | 138 | 7 | M3677 | |
| Coexpression | GSE3982_DC_VS_TH2_DN | 9.16e-05 | 199 | 138 | 7 | M5486 | |
| Coexpression | GSE27786_NKTCELL_VS_MONO_MAC_DN | 9.45e-05 | 200 | 138 | 7 | M4871 | |
| Coexpression | ZHAN_MULTIPLE_MYELOMA_PR_DN | 1.30e-04 | 49 | 138 | 4 | M10412 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DNAH10 MYO7B SPTA1 GRM1 SLC8A1 FAT1 PIEZO2 TRANK1 OTOGL MYOM2 HYDIN | 1.57e-11 | 184 | 139 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DNAH10 MYO7B SPTA1 GRM1 SLC8A1 FAT1 PIEZO2 TRANK1 OTOGL MYOM2 HYDIN | 1.57e-11 | 184 | 139 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DNAH10 MYO7B SPTA1 GRM1 SLC8A1 FAT1 PIEZO2 TRANK1 OTOGL MYOM2 HYDIN | 1.57e-11 | 184 | 139 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | NS-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.87e-07 | 195 | 139 | 8 | 34e37cff4849696ca4ba5dd8fd2cf98fed8bc912 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.02e-07 | 197 | 139 | 8 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.02e-07 | 197 | 139 | 8 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.02e-07 | 197 | 139 | 8 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.02e-07 | 197 | 139 | 8 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.39e-07 | 157 | 139 | 7 | ec433d2fe827abdb647be4176c231b7052482b6f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-06 | 169 | 139 | 7 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.72e-06 | 182 | 139 | 7 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-06 | 183 | 139 | 7 | a97f052950429245c3231464271e1ba539863bba | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.06e-06 | 187 | 139 | 7 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.21e-06 | 189 | 139 | 7 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | Ciliated|World / shred by cell class for parenchyma | 2.21e-06 | 189 | 139 | 7 | 711181ca3b9102fb155168b646b0a9b09ff215b2 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 2.29e-06 | 190 | 139 | 7 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 2.37e-06 | 191 | 139 | 7 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | Healthy_Control-Epithelial-Epithelial-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.37e-06 | 191 | 139 | 7 | 28caedb2e448e0c7f494100d714fa7cdcf150691 | |
| ToppCell | Healthy_Control-Epithelial-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.37e-06 | 191 | 139 | 7 | 15b9386b26caaa7d15f704c4a18881e1ce918a21 | |
| ToppCell | Healthy_Control-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.37e-06 | 191 | 139 | 7 | fdcdadbfc9ccae175abe4de8c7428ac4f6a67fde | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.54e-06 | 193 | 139 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.72e-06 | 195 | 139 | 7 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | BL-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.72e-06 | 195 | 139 | 7 | 07a6bcef6af93ed87df455dee624037cb75e011a | |
| ToppCell | Caecum-(2)_B_cell-(21)_B_cell_IgG_Plasma|Caecum / shred on region, Cell_type, and subtype | 3.00e-06 | 198 | 139 | 7 | 3893fcfc1de5937be3ccc7e545f711f2c95a2827 | |
| ToppCell | Caecum-B_cell-B_cell_IgG_Plasma|Caecum / Region, Cell class and subclass | 3.00e-06 | 198 | 139 | 7 | d8cb78b1763710a158cf22b59aebaa44afd2374c | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.10e-06 | 199 | 139 | 7 | 2498237b9e895ca4826a3378d9d40989968df72b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.10e-06 | 199 | 139 | 7 | 542ec45c931b40738df1f3777b00c83be33a514a | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.21e-06 | 200 | 139 | 7 | 926a7ea94b5908aebf103893ea83ce9d25285b65 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.21e-06 | 200 | 139 | 7 | 5abd6d81e1cc354484ae693fcd708d78926e75b5 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 3.21e-06 | 200 | 139 | 7 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.21e-06 | 200 | 139 | 7 | 9c9d2b0276c7b0709c2eeeb0673a2f58106fb14e | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.21e-06 | 200 | 139 | 7 | 06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast-MyoFB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 6.38e-06 | 145 | 139 | 6 | ac41c6c02b7d78162b86222983688f54d04ac47d | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 158 | 139 | 6 | 1d78578dc1f8ba43dacdccae1082c0b9d749f64d | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-05 | 163 | 139 | 6 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-05 | 163 | 139 | 6 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-05 | 169 | 139 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-like-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.63e-05 | 171 | 139 | 6 | ca2775a17b5c339c480a963953b6fa2b0731f24d | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.63e-05 | 171 | 139 | 6 | 3ad4f138d9570500cfb4423a2be16bb7d1cacbf8 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.25e-05 | 181 | 139 | 6 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 2.32e-05 | 182 | 139 | 6 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.32e-05 | 182 | 139 | 6 | 975f6275777fc578eba528e50f69891c66ec44ad | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.32e-05 | 182 | 139 | 6 | f8c28fa76751062c4cfba0db8af1b377f947f739 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 2.39e-05 | 183 | 139 | 6 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.54e-05 | 185 | 139 | 6 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Ciliated_cells-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 2.54e-05 | 185 | 139 | 6 | d77ca57b02125a3a57a37f4aed20c89803b7d551 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.62e-05 | 186 | 139 | 6 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.70e-05 | 187 | 139 | 6 | 88f785932e67c613db0dda84496de351359ed962 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.70e-05 | 187 | 139 | 6 | 8896a00b30d11b90ca42726d4e122174a30b161b | |
| ToppCell | Ciliated_cells-B-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 2.70e-05 | 187 | 139 | 6 | bc1f33f332ac939c2425f510173430ca2ba0c3ee | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.78e-05 | 188 | 139 | 6 | 82c006f43c93f4a867953a446864f02b44536a23 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.78e-05 | 188 | 139 | 6 | da59b5c0a4b11690a39a964c1a0a83e66aa0972b | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.78e-05 | 188 | 139 | 6 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | ILEUM-non-inflamed-(5)_Plasma-(5)_IgG_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.78e-05 | 188 | 139 | 6 | 2156f1bc849ff1cb09ae296d13bedd913ae6b43b | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.87e-05 | 189 | 139 | 6 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 2.95e-05 | 190 | 139 | 6 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.95e-05 | 190 | 139 | 6 | a90a38fccdbf75a286b4d258fc54920c02b282f7 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD4_rest-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.95e-05 | 190 | 139 | 6 | 69c5c4d5f4fb6e5ae2c9dbf9d209faf093c3f769 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.04e-05 | 191 | 139 | 6 | dad675251e129254955eac179c84a641a4864586 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 3.04e-05 | 191 | 139 | 6 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.04e-05 | 191 | 139 | 6 | 6d2cf41ee946137c039ddcc13593fc3f670afbba | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.04e-05 | 191 | 139 | 6 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.04e-05 | 191 | 139 | 6 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.04e-05 | 191 | 139 | 6 | e81cd65dbf0ef1c2ab7088f73ce605d456dd3a7a | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.04e-05 | 191 | 139 | 6 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.13e-05 | 192 | 139 | 6 | 1b6cac8156e608061e1405e36e18d185b6fa8f6f | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 3.13e-05 | 192 | 139 | 6 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.22e-05 | 193 | 139 | 6 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 3.22e-05 | 193 | 139 | 6 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 3.22e-05 | 193 | 139 | 6 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.32e-05 | 194 | 139 | 6 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | ASK440-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.32e-05 | 194 | 139 | 6 | c84a7fa94fb06e08aae04db56c8c313b0afde1d7 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.32e-05 | 194 | 139 | 6 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.32e-05 | 194 | 139 | 6 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 3.32e-05 | 194 | 139 | 6 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.32e-05 | 194 | 139 | 6 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | normal_Lung-Epithelial_cells-Ciliated|Epithelial_cells / Location, Cell class and cell subclass | 3.42e-05 | 195 | 139 | 6 | a3e2999fdd4c3575add6e28ecfd1d6606a61f992 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.42e-05 | 195 | 139 | 6 | 649fd2336e963f6a150d182a53ad5dd838ca80b1 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.42e-05 | 195 | 139 | 6 | d211a836cf711fdb91b10d512f09d462be937cc5 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.42e-05 | 195 | 139 | 6 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.42e-05 | 195 | 139 | 6 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | COVID-19_Moderate-CD8+_T_activated|World / disease group, cell group and cell class | 3.42e-05 | 195 | 139 | 6 | 070c5d3bdbd4ea54a579c01c37fb99bcf823982e | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.42e-05 | 195 | 139 | 6 | 129ad5f4253ecb1a8477cc38773e6e91ea9570b0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.42e-05 | 195 | 139 | 6 | 3e70ee987d66d450062d5df3d7c733ccc7344470 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.42e-05 | 195 | 139 | 6 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.52e-05 | 196 | 139 | 6 | a37ba02446eef5d1fab703204583f6550a8ec3e1 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.52e-05 | 196 | 139 | 6 | a156840330630e518bc85633dded6f2c3ead3b30 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.52e-05 | 196 | 139 | 6 | 009e83c7251cf300be78b263634d233a8d972a68 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated-diff|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.52e-05 | 196 | 139 | 6 | 9a91a6e5f93ce3bb5a0fc63677553f4c2df95c43 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.52e-05 | 196 | 139 | 6 | 89ea4d2086e1c769c5a87f1471a6cd4acabcfe33 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.52e-05 | 196 | 139 | 6 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.62e-05 | 197 | 139 | 6 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | facs-Trachea-3m|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.62e-05 | 197 | 139 | 6 | e77016d64b1cac9825fec7cfe5071f1567401187 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-05 | 197 | 139 | 6 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.62e-05 | 197 | 139 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | facs-Trachea-nan-3m|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-05 | 197 | 139 | 6 | 0353d925ee4b7aefc2c51b5fab873f465cdf9ebc | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.72e-05 | 198 | 139 | 6 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.83e-05 | 199 | 139 | 6 | 15f7814b7074170eee7ccacaa670b1d128fc68bb | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.83e-05 | 199 | 139 | 6 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | (10)_Ciliated|World / shred by cell type by condition | 3.93e-05 | 200 | 139 | 6 | 1b6a8025bd2746b626040058c122b1be3ab2fa61 | |
| Drug | Ozagrel hydrochloride [78712-43-3]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 3.46e-06 | 198 | 138 | 9 | 5983_DN | |
| Drug | GBR 12909 dihydrochloride [67469-78-7]; Down 200; 7.6uM; HL60; HG-U133A | 3.46e-06 | 198 | 138 | 9 | 1625_DN | |
| Disease | mean platelet volume | RBBP5 SPTA1 RTTN NUCB2 STK38 JMJD1C ZNF710 NARF TRANK1 ZBED4 AP1B1 AP2B1 SYNE2 N4BP2L2 TBCA | 8.28e-05 | 1020 | 137 | 15 | EFO_0004584 |
| Disease | brain ischemia (biomarker_via_orthology) | 1.16e-04 | 102 | 137 | 5 | DOID:2316 (biomarker_via_orthology) | |
| Disease | ceramide measurement | 1.19e-04 | 235 | 137 | 7 | EFO_0010222 | |
| Disease | inflammatory biomarker measurement | 2.35e-04 | 26 | 137 | 3 | EFO_0004872 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 4.36e-04 | 291 | 137 | 7 | EFO_0008317, EFO_0020946 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 5.75e-04 | 144 | 137 | 5 | EFO_0004611, EFO_0020943 | |
| Disease | hemorrhoid | 6.32e-04 | 147 | 137 | 5 | EFO_0009552 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 6.92e-04 | 150 | 137 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | Intellectual Disability | 1.19e-03 | 447 | 137 | 8 | C3714756 | |
| Disease | response to hydrochlorothiazide, fasting blood glucose measurement | 1.28e-03 | 46 | 137 | 3 | EFO_0004465, EFO_0005202 | |
| Disease | complement component C7 measurement | 1.37e-03 | 12 | 137 | 2 | EFO_0008093 | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 1.37e-03 | 12 | 137 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 1.38e-03 | 103 | 137 | 4 | EFO_0008595, EFO_0020944 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.50e-03 | 264 | 137 | 6 | EFO_0008317, EFO_0020944 | |
| Disease | Connective Tissue Diseases | 1.61e-03 | 13 | 137 | 2 | C0009782 | |
| Disease | FEV/FEC ratio | MAP2 RBBP5 MSL1 JMJD1C FRMD4A ZNF106 SLC8A1 DST SRGAP3 SYNE2 YLPM1 DCAF17 FGL1 KPNA2 | 1.76e-03 | 1228 | 137 | 14 | EFO_0004713 |
| Disease | Hypertrophic Cardiomyopathy | 2.39e-03 | 57 | 137 | 3 | C0007194 | |
| Disease | DiGeorge Syndrome | 2.46e-03 | 16 | 137 | 2 | C0012236 | |
| Disease | interferon gamma measurement, platelet-derived growth factor BB measurement, interleukin 4 measurement, interleukin 10 measurement, stromal cell-derived factor 1 alpha measurement, interleukin-6 measurement, interleukin 12 measurement, interleukin 17 measurement, vascular endothelial growth factor measurement, fibroblast growth factor basic measurement, granulocyte colony-stimulating factor measurement | 2.46e-03 | 16 | 137 | 2 | EFO_0004750, EFO_0004753, EFO_0004762, EFO_0004810, EFO_0008130, EFO_0008142, EFO_0008165, EFO_0008174, EFO_0008184, EFO_0008264, EFO_0008293 | |
| Disease | CONOTRUNCAL ANOMALY FACE SYNDROME | 2.46e-03 | 16 | 137 | 2 | C0795907 | |
| Disease | Shprintzen syndrome | 2.46e-03 | 16 | 137 | 2 | C0220704 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 2.48e-03 | 121 | 137 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | fibrinogen measurement, factor VII measurement | 2.51e-03 | 58 | 137 | 3 | EFO_0004619, EFO_0004623 | |
| Disease | platelet component distribution width | SPTA1 RTTN STK38 JMJD1C ZNF710 TRANK1 AP2B1 N4BP2L2 AKAP13 TBCA | 2.83e-03 | 755 | 137 | 10 | EFO_0007984 |
| Disease | platelet-derived growth factor BB measurement | 2.89e-03 | 61 | 137 | 3 | EFO_0008264 | |
| Disease | free cholesterol in very large VLDL measurement | 2.89e-03 | 61 | 137 | 3 | EFO_0022274 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 2.96e-03 | 127 | 137 | 4 | EFO_0008595, EFO_0020947 | |
| Disease | Grand Mal Status Epilepticus | 3.78e-03 | 67 | 137 | 3 | C0311335 | |
| Disease | Status Epilepticus, Subclinical | 3.78e-03 | 67 | 137 | 3 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 3.78e-03 | 67 | 137 | 3 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 3.78e-03 | 67 | 137 | 3 | C0751523 | |
| Disease | Petit mal status | 3.78e-03 | 67 | 137 | 3 | C0270823 | |
| Disease | Complex Partial Status Epilepticus | 3.78e-03 | 67 | 137 | 3 | C0393734 | |
| Disease | dilated cardiomyopathy | 3.85e-03 | 20 | 137 | 2 | EFO_0000407 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 3.86e-03 | 222 | 137 | 5 | EFO_0008317, EFO_0020943 | |
| Disease | Status Epilepticus | 3.94e-03 | 68 | 137 | 3 | C0038220 | |
| Disease | free cholesterol in large VLDL measurement | 3.94e-03 | 68 | 137 | 3 | EFO_0022265 | |
| Disease | haptoglobin measurement | 4.24e-03 | 21 | 137 | 2 | EFO_0004640 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EEKLFLLADEVYQDN | 291 | Q8TD30 | |
| LEDDQENTLKYEYEE | 486 | Q5RHP9 | |
| QETFKIVDYEDELDL | 421 | Q5H9S7 | |
| DSYDIVLEKDETLDV | 266 | Q969T7 | |
| EVYADADEILQEEIK | 926 | O75150 | |
| YEEIKEYEKLDNEED | 86 | P35626 | |
| QEELTELKDEISLYE | 471 | O94986 | |
| EYKSELDERAVQEIE | 821 | Q8IVF6 | |
| AELKEYATEVDVDFV | 356 | P63010 | |
| QLKLQFEELEVDYEA | 56 | Q8TD16 | |
| AELAEIYAKLEEIEA | 286 | Q9NUQ8 | |
| AEEDKAEDDVVFYLV | 21 | Q12802 | |
| LKEFKTIQEEEYTEE | 846 | A6QL63 | |
| AELKEYATEVDVDFV | 356 | Q10567 | |
| YAIIKEELDEDFEQL | 1086 | Q6PL18 | |
| EKETLAVNYEKEEEF | 126 | Q16204 | |
| AVNYEKEEEFLTNEL | 131 | Q16204 | |
| EKRVEYAVLDELEDF | 191 | Q8WYQ5 | |
| KDESVDLEEFRSYLE | 431 | Q8WYQ5 | |
| DLYEEILTEEGTAKE | 56 | Q9UKL3 | |
| TNRDEALDKVYEEIE | 681 | O43520 | |
| EEEKKQLEGEIIDFY | 11 | C0HM01 | |
| TDELEIIDEYIKENG | 51 | Q01201 | |
| DLEKIFSEDDDYIDI | 81 | P05546 | |
| EDEEIYKEFFEVAND | 361 | O00255 | |
| LQDIEEKQEYLLEFE | 1336 | Q8N7Z5 | |
| ETNVLDDEIDSYFKE | 276 | Q8N635 | |
| EEEEEDVLKYVREIF | 141 | Q9BWK5 | |
| EFLQESYFVEVSEDK | 821 | Q14517 | |
| ALDLLEYIDEEEDIN | 1051 | Q8WUM0 | |
| YVEFDEVDSLKEALT | 86 | Q15056 | |
| YNLGKEEIEDLSDEV | 811 | A0AUZ9 | |
| RFTELYVEELESKED | 901 | Q9NU22 | |
| DYKNEEVKFIENELE | 606 | Q7Z353 | |
| AELVEFLLLKYEAEE | 146 | Q9UBF1 | |
| LEEFHYQTKEDQEIL | 766 | Q3B7T1 | |
| YQLTEEGTFKVVDEE | 216 | P0C870 | |
| LQEELEKFDADYTEF | 3921 | Q03001 | |
| EEFDSLYSILDEVKE | 81 | Q9BXM9 | |
| ADIEYLEDVKVENED | 661 | Q17RB8 | |
| NFEDDELDIETSKYI | 1791 | Q15652 | |
| YLLFADKEDIIFDIE | 471 | Q9BZQ6 | |
| DKEDIIFDIEDYIFT | 476 | Q9BZQ6 | |
| LNVLEEYITDEQKEE | 106 | Q8IZU0 | |
| FSLIIDDTEYEKEVL | 5586 | Q5CZC0 | |
| FDAYLEEEVLDKSQT | 81 | Q5JST6 | |
| LVLIKDYEAAEEEEA | 326 | Q96BY2 | |
| TVTLQEFEEEIAKYD | 536 | Q9ULD0 | |
| ELERYKEENIELAFD | 831 | Q92614 | |
| KFQFELTLEEEEEEE | 706 | P27815 | |
| LNFEEIDYKEIEVEE | 26 | O43318 | |
| LVQEIDFLKSLYEEE | 246 | Q9NSB4 | |
| TALFYTLEKEEEEDR | 511 | Q9NX02 | |
| KLFQGYETEEREETE | 281 | Q68DK7 | |
| FFTEEELKEYENIIA | 341 | P80303 | |
| LLEEEEDINQITDYF | 881 | Q06190 | |
| YVDFESAEDLEKALE | 351 | P19338 | |
| FKELDENVEYEERES | 336 | Q15291 | |
| TDDELDAYIEDLITK | 1016 | Q9Y6X9 | |
| EDDLFEDKQENRYLV | 376 | Q8NB91 | |
| LIEKYFSVEEEEDQN | 491 | P52292 | |
| TIDKLLLEEEDSDAY | 231 | Q16633 | |
| IEYENQKRLEEEEDL | 766 | P36888 | |
| IYKELIDVDSEVVFE | 126 | Q9P2Q2 | |
| FKEVAEAYEVLSNDE | 46 | Q7Z6W7 | |
| QVAKLEDDIYKEAEE | 1331 | B1AJZ9 | |
| LLVESKTYLEEEEDE | 1966 | Q4G0P3 | |
| EYDALTEEEKLTFDR | 2306 | Q4G0P3 | |
| IESLENLYLDFDDDV | 386 | Q659A1 | |
| EAEGEKYIEEILDQI | 231 | Q13325 | |
| EEEYETLENVTDLLK | 41 | Q9BX69 | |
| EDDLLLQFDVEDLYE | 126 | O60678 | |
| YEEALSQLEESVKEE | 646 | Q8N8A6 | |
| TQEDYTLKIDLADFE | 166 | Q08830 | |
| KEESSIYDDIVFVDV | 311 | Q8NCR0 | |
| LEEKDGVDTELLVYA | 251 | Q2V2M9 | |
| KFACETIIEEYEDEI | 46 | Q3B7I2 | |
| ILDKIIEEDDAYDFS | 531 | Q9BVP2 | |
| LAKYISAEDDDLAVE | 311 | Q8WUQ7 | |
| NESFKRYEEELEIND | 926 | Q7L014 | |
| DDDDSERFKLLQEYV | 1096 | Q13255 | |
| QYLIKLEEEDEDEED | 386 | P17655 | |
| DYEAAKALFQEILEE | 2751 | Q8IVF4 | |
| VNYTEEEIDALLKED | 51 | Q96BU1 | |
| DVREEDSYLFDLDNK | 1166 | Q9H9B1 | |
| EEIETAIKEYSEELV | 226 | Q9UHY8 | |
| DDFIILQEDYTEDIA | 266 | Q3ZCN5 | |
| KVLQSDEYEEVEDKT | 591 | O15397 | |
| DVEAEKQLIREEYEE | 401 | Q9P2E2 | |
| TKSEEDLFLQVYEDL | 171 | Q9NWW6 | |
| EKKAQLEEEIIAYEE | 771 | Q8TBY8 | |
| VEKVYEIFTSDDVDL | 831 | Q86VV8 | |
| FYEEKEVDLSDIINT | 106 | P49848 | |
| DLDETLYVQETEKAE | 66 | Q9H7C4 | |
| KDTLTEEETQFYIAE | 181 | Q15208 | |
| YDDEDISEDIKFLLE | 326 | Q9UI12 | |
| LEEAKEEEELNYVID | 71 | A8MYB1 | |
| LEFLEVQEEYIKDEQ | 51 | P43686 | |
| DLTDEEKQEYLNEYE | 106 | Q969G3 | |
| EEFDENYASLEKDLE | 4841 | Q8WXH0 | |
| IKIHTLSYDVEEEEE | 141 | Q9H7V2 | |
| KDFELDVLEEAYTTE | 671 | P46977 | |
| QDEQLDLDFVEAKYT | 126 | Q9P2F8 | |
| ADFFEDEAIEQILKY | 201 | Q6PI26 | |
| EDLFDIEDDIIYTQD | 351 | Q15831 | |
| KYETDAIQRTEELEE | 1376 | P13533 | |
| GLEVDVAEYKEEELL | 711 | Q01826 | |
| LSFEEKPVYIQDLDE | 451 | Q8N3C0 | |
| EEFYKSEDGENLEIL | 711 | Q9BXT8 | |
| EIFDTEKEKYEITEQ | 231 | Q02878 | |
| DEEVEQIEAIAKFDY | 741 | O43295 | |
| FYQEEIQERDEKIEE | 636 | O95235 | |
| DIQYFDKLLVDVDES | 471 | O75533 | |
| EYKELLQEFIDSDAA | 41 | O75556 | |
| LENYEKEDITVAELE | 2486 | Q9H5I5 | |
| FEKVEEEEQEVYEVS | 111 | Q8N1W2 | |
| YEEAREIFVDEDKTI | 76 | Q9BZD6 | |
| LEDYTAFLIDKESEN | 2336 | P02549 | |
| TDAEIEAIFTKYDQD | 751 | Q13563 | |
| EYKELLQEFIDDNAT | 41 | Q13296 | |
| LDDYFITEVEKEEKD | 1871 | P49750 | |
| EEEIEAQGEYDKLLF | 1236 | P11137 | |
| IEVYEEQISFKLEEL | 546 | Q7Z3V4 | |
| EEEFVEGIYKVEIDT | 81 | P02766 | |
| EELDESYIEKFTDFL | 361 | Q96QU8 | |
| ATFYDIETLKVIDEE | 91 | O43915 | |
| FLSQELLYKEETLDE | 351 | Q9H497 | |
| EIDLVSLEEFYKEAP | 156 | Q13769 | |
| QEELFEEAAIAVEKY | 1831 | O15050 | |
| EEREQDIEDQLYKLE | 201 | Q9BZR9 | |
| FLEKNYTDEAIETDD | 171 | O14818 | |
| ILENEKDLEEAEEYK | 81 | O75347 | |
| EEEEDYFDKELIQLI | 61 | Q9H2Y7 | |
| LKIVELDDTYEEEFE | 391 | A8MT70 | |
| VDASYIDEIDELFKE | 81 | Q9BXU0 | |
| LFTEEEAEQYKQDLI | 1016 | O75132 | |
| EYEELFENLAEIVKA | 5246 | Q9UKN1 | |
| IDDEEYEKNKTFFLE | 611 | P32418 | |
| VDDEEYEKKDNFFIE | 596 | Q9UPR5 | |
| KIVDEEEYERQENFF | 601 | P57103 | |
| AAKELFNEDVEEVTY | 306 | Q9UHQ1 | |
| SEIDNELFQFYKEIE | 166 | Q92802 | |
| SGEYSFEKEEELVEL | 1316 | Q6PIF6 | |
| LEGEKEIAIYQDDLE | 491 | P54296 |